Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;37(11):2123-2128.
doi: 10.3174/ajnr.A4859. Epub 2016 Jun 30.

Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy

Affiliations

Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy

Y Kaichi et al. AJNR Am J Neuroradiol. 2016 Nov.

Abstract

Background and purpose: The quantitative evaluation of orbital fat proliferation and edema and the assessment of extraocular muscles are useful for diagnosing and monitoring thyroid-associated orbitopathy. To evaluate therapy-induced quantitative changes in the orbital fat of patients with thyroid-associated orbitopathy, we performed volumetric and water fraction measurements by using T2-weighted FSE iterative decomposition of water and fat with echo asymmetry and least-squares estimation (FSE-IDEAL) imaging.

Materials and methods: Orbital FSE-IDEAL images of 30 volunteers were acquired twice within 1 week. Nine patients with thyroid-associated orbitopathy underwent FSE-IDEAL imaging before and after methylprednisolone pulse therapy, and the treatment results were assessed by using their pre- and post-methylprednisolone pulse therapy clinical activity scores. We performed volumetric and water fraction measurements of orbital fat by using FSE-IDEAL imaging and evaluated interscan differences in the volunteers. In patients with thyroid-associated orbitopathy, we compared pre- and posttherapy orbital fat measurements and assessed the correlation between the pretherapy values and clinical activity score improvement.

Results: The reproducibility of results obtained by the quantitative evaluation of orbital fat in volunteers was acceptable. After methylprednisolone pulse therapy, the water fraction in the orbital fat of patients with thyroid-associated orbitopathy was significantly decreased (P < .001). There was a significant positive correlation between the pretherapy water fraction and clinical activity score improvement (right, r = 0.82; left, r = 0.79) and a significant negative correlation between the pretherapy volume and clinical activity score improvement (bilateral, r = -0.84).

Conclusions: Volumetric and water fraction measurements of orbital fat by using FSE-IDEAL imaging are feasible and useful for monitoring the effects of therapy and for predicting the response of patients with thyroid-associated orbitopathy to methylprednisolone pulse therapy.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Axial water (A) and fat (B) images of a healthy volunteer. The ROIs are encircled in yellow.
Fig 2.
Fig 2.
Axial fat image (A) of a healthy volunteer. The selected orbital fat is light green. We separated fat tissue by using an adequate signal-intensity threshold and manually removed extraorbital fat. In this volunteer, the internal rectus muscle showed an average SI of 207 and an SD of 112, whereas the orbital fat showed an average SI of 1636 and an SD of 88. Therefore the threshold value was [(207 + 112) + (1636 − 88) / 2 = 933]. Using FSE-IDEAL images, we then produced 3D reconstruction images of the bilateral orbital fat (B) and measured the orbital fat volume on a workstation.
Fig 3.
Fig 3.
Bland-Altman analysis confirming the interscan reproducibility of the water fraction (A) and the volume of orbital fat (B) on FSE-IDEAL images of the volunteers.
Fig 4.
Fig 4.
Comparison of the pre- and posttreatment water fraction (A) and the volume of orbital fat (B) in patients with TAO. Methylprednisolone pulse therapy significantly decreased the water fraction. The volume was unchanged.

Similar articles

Cited by

References

    1. Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol 1993;111:197–201 10.1001/archopht.1993.01090020051022 - DOI - PubMed
    1. Winand RJ, Cornet G, Etienne-Decerf J, et al. . Original acquisition in the pathogenesis and the treatment of endocrine ophthalmopathy. Metab Pediatr Syst Ophthalmol 1988;11:126–32 - PubMed
    1. Kahaly G, Hansen C, Beyer J, et al. . Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994;17:45–50 10.1007/BF03344962 - DOI - PubMed
    1. Ludgate M, Baker G. Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 2002;127:193–98 10.1046/j.1365-2249.2002.01792.x - DOI - PMC - PubMed
    1. Rundle FF, Wilson CW. Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin Sci 1945;5:177–94 - PubMed

LinkOut - more resources